Literature DB >> 30481808

Short Tear Film Breakup Time-Type Dry Eye.

Kazuo Tsubota1.   

Abstract

Measurement of tear film breakup time (TBUT) has become a standard diagnostic procedure in the dry eye clinic. Short TBUT-type dry eye is characterized by TBUT of less than 5 seconds and dry eye symptoms such as ocular fatigue or dryness; the importance of this type has recently been gaining prominence. Patients with this condition show no reduction in tear production and no staining of the ocular surface. The severity of symptoms is almost the same as in dry eye in which the ocular surface is stained with rose bengal or fluorescein. In addition to discomfort, patients suffer from decreased vision due to the unstable tear film, which can be attributed to the relative abnormality of the lipid layer, aqueous layer, and/or mucin layer. The diagnosis should be performed carefully on the basis of the patient's symptoms and the TBUT test, because the ocular surface appears normal and remains unstained.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30481808     DOI: 10.1167/iovs.17-23746

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease.

Authors:  Biljana Kuzmanović Elabjer; Leon Marković; Mirjana Bjeloš; Mladen Bušić; Daliborka Miletić; Eva Kos
Journal:  Clin Ophthalmol       Date:  2020-10-30

Review 2.  Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered.

Authors:  Gysbert-Botho van Setten
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

3.  Lipid polarity gradient formed by ω-hydroxy lipids in tear film prevents dry eye disease.

Authors:  Masatoshi Miyamoto; Takayuki Sassa; Megumi Sawai; Akio Kihara
Journal:  Elife       Date:  2020-04-07       Impact factor: 8.140

4.  Ocular Surface Workup in Patients with Meibomian Gland Dysfunction Treated with Intense Regulated Pulsed Light.

Authors:  Luca Vigo; Leonardo Taroni; Federico Bernabei; Marco Pellegrini; Stefano Sebastiani; Andrea Mercanti; Nicola Di Stefano; Vincenzo Scorcia; Francesco Carones; Giuseppe Giannaccare
Journal:  Diagnostics (Basel)       Date:  2019-10-13

5.  Effect of ocular demodicosis on the stability of the tear film and the tear break up time.

Authors:  Aleksandra Sędzikowska; Witold Tarkowski; Joanna Moneta-Wielgoś; Krzysztof Grzyliński; Grzegorz Tarkowski; Daniel Młocicki
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

6.  Short tear film breakup time-type of dry eye in India.

Authors:  Samrat Chatterjee; Deepshikha Agrawal
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

7.  Advances in Dry Eye Disease Examination Techniques.

Authors:  Yaying Wu; Chunyang Wang; Xin Wang; Yujie Mou; Kelan Yuan; Xiaodan Huang; Xiuming Jin
Journal:  Front Med (Lausanne)       Date:  2022-01-25

8.  Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional study.

Authors:  Takenori Inomata; Masahiro Nakamura; Jaemyoung Sung; Akie Midorikawa-Inomata; Masao Iwagami; Kenta Fujio; Yasutsugu Akasaki; Yuichi Okumura; Keiichi Fujimoto; Atsuko Eguchi; Maria Miura; Ken Nagino; Hurramhon Shokirova; Jun Zhu; Mizu Kuwahara; Kunihiko Hirosawa; Reza Dana; Akira Murakami
Journal:  NPJ Digit Med       Date:  2021-12-20

9.  An in vivo confocal microscopy study of corneal changes in patients with systemic sclerosis.

Authors:  Eszter Szalai; Gabriella Szucs; Szilvia Szamosi; Zsuzsa Aszalos; Ildiko Afra; Adam Kemeny-Beke
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

10.  Meibomian Gland Dysfunction: Intense Pulsed Light Therapy in Combination with Low-Level Light Therapy as Rescue Treatment.

Authors:  Leonidas Solomos; Walid Bouthour; Ariane Malclès; Gabriele Thumann; Horace Massa
Journal:  Medicina (Kaunas)       Date:  2021-06-14       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.